News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GammaCan International, Inc. (GCAN.OB) to Present and Webcast at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference


5/14/2007 12:09:12 PM

KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--GammaCan International, Inc. ("GammaCan" or "the Company") (OTCBB:GCAN), a developer of immunotherapies for the treatment of cancer, today announced that Patrick Schnegelsberg, Chief Executive Officer, is scheduled to present VitiGam™, GammaCan's lead product under development for the treatment of Stage III and Stage IV melanoma at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference. GammaCan’s presentation is scheduled for Monday, May 14th at 2:55 PM CST (8:55 AM EDT).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES